Scroll Top

GenSight Biologics confirms the success of its IPO by exercising 88.9% of the over-allotment option

lab
Archives
Categories
RECENT POSTS

http://gensight-biologics.com/index.php?mact=News1,cntnt01,detail,0&cntnt01item_id=12&cntnt01returnid=37